Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or wasting syndrome.
about
Pharmacokinetics of drugs in cachectic patients: a systematic reviewPopulation pharmacokinetics of ritonavir-boosted saquinavir regimens in HIV-infected individuals.Caring for women living with HIV: gaps in the evidence.Estimation of population pharmacokinetic parameters of saquinavir in HIV patients with the MONOLIX software.
P2860
Enhanced saquinavir exposure in human immunodeficiency virus type 1-infected patients with diarrhea and/or wasting syndrome.
description
2004 nî lūn-bûn
@nan
2004 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2004 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
name
Enhanced saquinavir exposure i ...... rrhea and/or wasting syndrome.
@ast
Enhanced saquinavir exposure i ...... rrhea and/or wasting syndrome.
@en
type
label
Enhanced saquinavir exposure i ...... rrhea and/or wasting syndrome.
@ast
Enhanced saquinavir exposure i ...... rrhea and/or wasting syndrome.
@en
prefLabel
Enhanced saquinavir exposure i ...... rrhea and/or wasting syndrome.
@ast
Enhanced saquinavir exposure i ...... rrhea and/or wasting syndrome.
@en
P2093
P2860
P1476
Enhanced saquinavir exposure i ...... arrhea and/or wasting syndrome
@en
P2093
Alissi Kodjo
Charles Caulin
Daniel Vittecoq
France Mentré
Hervé Trout
Jean-Gérard Gobert
Lélia Escaut
Pascal Pernet
Xavière Panhard
P2860
P304
P356
10.1128/AAC.48.2.538-545.2004
P407
P577
2004-02-01T00:00:00Z